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Abstract
Phenotypic drug discovery requires billions of cells for high-throughput screening (HTS) campaigns. Because up to several
million different small molecules will be tested in a single HTS campaign, even small variability within the cell populations
for screening could easily invalidate an entire campaign. Neurodegenerative assays are particularly challenging because
neurons are post-mitotic and cannot be expanded for implementation in HTS. Therefore, HTS for neuroprotective
compounds requires a cell type that is robustly expandable and able to differentiate into all of the neuronal subtypes
involved in disease pathogenesis. Here, we report the derivation and propagation using only small molecules of human
neural progenitor cells (small molecule neural precursor cells; smNPCs). smNPCs are robust, exhibit immortal expansion, and
do not require cumbersome manual culture and selection steps. We demonstrate that smNPCs have the potential to
clonally and efficiently differentiate into neural tube lineages, including motor neurons (MNs) and midbrain dopaminergic
neurons (mDANs) as well as neural crest lineages, including peripheral neurons and mesenchymal cells. These properties are
so far only matched by pluripotent stem cells. Finally, to demonstrate the usefulness of smNPCs we show that mDANs
differentiated from smNPCs with LRRK2 G2019S are more susceptible to apoptosis in the presence of oxidative stress
compared to wild-type. Therefore, smNPCs are a powerful biological tool with properties that are optimal for large-scale
disease modeling, phenotypic screening, and studies of early human development.
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Introduction
Stem cells are positioned to revolutionize drug discovery for
neurodegenerative disorders through in vitro disease modeling and
HTS. Through reprogramming of primary cells from a patient,
induced pluripotent stem cells (iPSCs) can be generated with
properties comparable to human embryonic stem cells (hESCs)
[1]. For example, two groups have reported that midbrain
dopaminergic neurons (mDANs) differentiated from iPSCs gener-
ated from patients with Parkinson’s disease (PD) with mutations in
the gene LRRK2 exhibit disease-associated phenotypes [2,3].
Similarly, it has been demonstrated that motor neurons (MNs)
differentiated from hESCs with mutations causing amyotrophic
lateral sclerosis (ALS) are susceptible to degeneration [4]. In
principle, the phenotypes exhibited by patient-specific cells could
be used in high-throughput screening (HTS) campaigns to identify
novel neuroprotective compounds for development into new
drugs.
Because HTS campaigns can involve up to several million
independent wells, the reproducibility of the assay must be
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extremely high, or else the results will be uninterpretable.
Consequently, for the promise of stem cells to become realized
at least two hurdles must be overcome. First, HTS using models of
neurodegenerative diseases requires cells that are characterized by
very robust expansion to produce billions of cells under chemically
defined conditions. Second, these cells must be capable of efficient
formation of neurons such as mDANs and MNs. However, current
stem cell protocols are not robust, require expensive recombinant
growth factors, involve manual manipulation, have need of
frequent splitting at narrow ratios, need significant time for
differentiation, and/or result in inefficient differentiation. As
a result, stem cell cultures typically exhibit tremendous variability
and, as a result, it is often difficult to reproducibly obtain
a statistically significant result using triplicate wells. Therefore,
previous cell types including neural stem cells (NSCs) [5], long-
term self-renewing rosette-type hESC-derived NSCs (lt-hESNSCs)
[6], primitive NSCs (pNSCs) [7], and rosette neural cells (R-NCs)
[8], are not easily compatible with HTS. We have identified
a novel type of neural progenitor cells capable of robust, immortal
expansion and efficient differentiation into both central nervous
system (CNS) and neural crest lineages. These properties are so far
only matched by pluripotent stem cells. Additionally, our neural
precursor cells only require small molecules for self-renewal and
expansion, a feature that significantly reduces the cost of large-
scale disease modeling and, to date, is not possible with any other
available cell type.
Although NSCs are competent to differentiate into CNS
lineages including neurons, astrocytes and oligodendrocytes, they
are not able to efficiently form mDANs or MNs, which makes
them unsuitable for neurodegenerative disease modeling [5,9].
Similar to NSCs, lt-hESNSCs, which are differentiated from
hESCs, use the same recombinant proteins as NSCs for self-
renewal – FGF2 and EGF – and express markers of ventral
hindbrain identity. When treated with the developmental
patterning factors Sonic hedgehog (SHH) and Fibroblast growth
factor 8 (FGF8) or SHH and retinoic acid (RA), about 70% of
differentiated neurons were not mDANs. When cultured with
SHH and retinoic acid (RA), about 85% of differentiated neurons
were not MNs. These results make large-scale modelling of PD
and ALS problematic. In addition, lt-hESNSCs require splitting
three or more times per week at very low ratios, which makes
expansion to billions of cells for HTS very tedious and
cumbersome.
Two cell types have been reported with increased differentiation
potential. Primitive NSCs (pNSCs) could efficiently be differenti-
ated into mDANs (about 55%) and MNs (about 54%). However,
pNSCs require recombinant Leukemia inhibitory factor (LIF) for
self-renewal, which makes them very cost-intensive to culture in
large quantities and, therefore, impractical for HTS. Elkabetz
et alia reported the derivation of rosette-neural cells (R-NCs) from
hESCs [8]. R-NCs could be differentiated into both CNS and
neural crest lineages. However, despite the use of high doses of
recombinant growth factors, R-NCs were only expandable for up
to 4 passages before differentiating. As a result, it is not possible to
generate enough R-NCs for even a pilot study to validate an HTS
assay let alone an entire HTS campaign. As a result, it is urgently
necessary to derive a cell type that is both plastic and can be
propagated in a manner compatible with HTS.
We speculated that signals present in the neural plate border
region may be sufficient to direct self-renewal of cells in vitro with
potential to differentiate into CNS and neural crest lineages
including peripheral nervous system (PNS) neurons. During
embryogenesis, neuroepithelial cells on the border between the
neural plate and neural crest have the developmental potential to
form neural tube-derived CNS lineages as well as neural crest-
derived lineages such as peripheral nervous system (PNS) neurons
[10,11]. WNT proteins specify formation of cells at the lateral
border of the neural plate and are potent mitogens [12].
Patterning by WNT proteins is antagonized by SHH, which
specifies ventral neural tube fates and is also a potent mitogen [12].
It is significant to note that SHH signaling was used by Elkabetz et
alia to culture R-NCs [8]. Because R-NCs could not be expanded
without committing to the CNS, we hypothesized that WNT
signaling in combination with SHH signaling might contribute to
the maintenance of precursors with developmental potential for
both neural crest and neural plate.
Here we report the derivation of human smNPCs, which have
properties uniquely suited to modeling neurodegenerative diseases.
We show that smNPCs can be efficiently specified into neural tube
and neural crest lineages. This developmental potential is similar
to R-NCs, and developmentally upstream of NSCs, lt-hESNSCs,
and pNSCs. Unlike R-NCs, we demonstrate that smNPCs are
capable of immortal self-renewal using WNT and SHH signals.
This combination is also distinct from FGF2 and EGF required for
NSCs and lt-hESNSCs. We show that culturing smNPCs with
FGF2 results in the formation of rosette-like structures, which have
been previously associated with the neural plate-stage of embryo-
genesis [13]. In addition, smNPCs are easy to handle, do not
require manual manipulation, and can be cultured at a wide range
of cell densities using only inexpensive small molecules. Finally, we
show that mDANs differentiated from smNPCs with the PD-
associated mutation LRRK2 G2019S are more sensitive to stress
compared to wild-type. Therefore, smNPCs are a robust and
affordable tool suitable for disease modeling.
Results
Derivation of a Population of Expandable Human Neural
Epithelial Cells
We tested the effects of introducing both WNT and SHH
signals to cultures of differentiating pluripotent stem cells. hESCs
and hiPSCs were differentiated via human embryoid bodies
(hEBs). Neural induction was initiated through inhibition of both
BMP and TGFb signaling using the small molecules dorsomor-
phin (DM) and SB43152 (SB) [14,15]. The small molecule
CHIR99021 (CHIR), a GSK3b inhibitor, was added to stimulate
the canonical WNT signaling pathway. The SHH pathway was
stimulated using the small molecule purmorphamine (PMA).
Differentiating hEBs exposed to CHIR and PMA were marked by
the formation and expansion of an epithelium (Figure 1A). These
epithelial cells expressed markers of neural progenitors including
SOX1, SOX2, NESTIN, and PAX6, but not mesodermal marker
T (Figure S1A). When disaggregated and plated on Matrigel,
homogeneous colonies of epithelial cells formed (Figure 1B). These
neural epithelial cells could be split enzymatically without manual
selection at a 1:10 to 1:20 ratio and expanded as cell lines for more
than 150 population doublings and exhibited a diploid karyotype
(Figure S1B). An analysis of doubling time indicated that neural
epithelial cells divided approximately once per day, which was
consistent over multiple passages as well as cultures derived from
multiple pluripotent stem cell lines (Figure S1C). Immunostaining
of neural epithelial cell colonies demonstrated the uniform
expression of the neural progenitor markers SOX1, SOX2,
NESTIN, and PAX6 (Figures 1C). Immunostaining also showed
the expression of FORSE1, which has been previously associated
with early neural progenitors (Figure 1C) [7]. Upon spontaneous
differentiation by withdrawal of the small molecules used for
expansion, smNPC differentiated into cells expressing NEUN/
Human Small Molecule-Expanded Neural Progenitors
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TUBBIII, GFAP/S100beta, and O4/OLIG2, which mark
neurons, astrocytes, and oligodendrocytes (Figures 1D and S2).
Therefore, neural epithelial cells express markers that are
characteristic of early neural progenitors. Interestingly, the cellular
morphology and culture conditions of the neural epithelial cells are
not typical of NSCs [5].
Neural epithelial cells after 20 passages were further character-
ized by microarray expression analysis. These cells did not express
the pluripotency markers OCT4 and NANOG, the mesendodermal
markers AFP, T, and SOX17, and the trophoblast marker EOMES
(Figure S3A). In contrast, neural epithelial cells showed high
expression of neural precursor markers, including SOX2, PAX6,
HES5, and ASCL1 (Figure S3A). qRT-PCR analysis confirmed
that neural epithelial cells express markers of neural progenitors,
including SOX2, SOX1, PAX6, and PAX3, which were stably
expressed beginning at about passage 5 (Table S1 and Figure
S3B). This suggests that neural epithelial cells stably expressed
markers of neural fate commitment after extensive cell culture
starting at about passage 4. qRT-PCR also confirmed that neural
epithelial cells did not express non-neural markers, including
OCT4, AFP, SOX17, CK8, CK18, and T, after 4 to 5 passages
(Figure S3B). This was achieved without any manual manipula-
tion, just by replating the cells under specific culture conditions
that strongly favored the expansion of these cells. These results
demonstrate that cultures of neural epithelial cells do not contain
subpopulations of cells expressing genetic markers of mesodermal,
endodermal, trophoblastic, or pluripotent cells.
Interestingly, although the neural epithelial cells do not
morphologically resemble neural rosettes, microarray analysis
demonstrated strong expression of the (pre-) neural rosette genetic
markers DACH1, PLZF, LMO3, NR2F1, PLAGL1, LIX1, and EVI1
(Figure S3A). This suggested that neural epithelial cells might have
the ability to form neural rosettes. To test this, we cultured neural
epithelial cell colonies in the presence of FGF2, which has
previously been reported to induce hEBs to form neural rosettes
[7,16]. After 2 days of culturing neural epithelial cell colonies in
the presence of FGF2, numerous areas were found to exhibit the
morphology of neural rosettes (Figure S4A). For further charac-
terization, we immunostained the neural epithelial cells for N-
CADHERIN and ZO-1, which is expressed by neural rosettes but
spatially localized to the apical surface [8]. Although N-
CADHERIN and ZO-1 expression were readily detected in
colonies of neural epithelial cells, they were not spatially localized
within the colonies (Figure S4B). In contrast, after FGF2
treatment, N-CADHERIN and ZO-1 expression were found at
the apical surface of the rosettes (Figure S4B). Therefore, neural
epithelial cells express early rosette markers and are capable of
forming neural rosettes when cultured under appropriate condi-
tions.
CHIR and PMA Modulate Expression of Markers of Neural
Crest and Ventral Neural Tube Identity in Human Neural
Epithelial Cells
Using microarray transcription profiling, we assessed the
expression of markers of regional identity by cultures neural
epithelial cells. PAX3, IRX3 and MSX1, which mark marginal
neural plate [17] or neural plate border cells [12], were readily
detectable in neural epithelial cells (Figure S5A). SOX9, which
marks neural crest cells, was also present, albeit to a lesser extent.
NKX6.1, OLIG2, NKX2.2, and FOXA2, which mark medial neural
plate and ventral neural tube, were not detected. GSH2, which
marks dorsal neural tube progenitors, was also not detected. Of the
tested rostrocaudal markers, only HOXA2 and HOXB2, which
mark anterior hindbrain identity, were highly expressed (Figure
S5B). This pattern is consistent with the neural plate border and
marginal neural plate region, which could suggest competence to
differentiate into CNS and PNS lineages [10,11,12,18]. However,
we are unaware of cells in vivo that express the same combination
of markers as smNPCs.
Next, we asked if altering the concentrations of CHIR and PMA
effected expression of lineage markers by cultures of neural
epithelial cells. To answer this, neural epithelial cells at passages
15–20 were cultured with different concentrations of CHIR and
PMA alone or in combination for 6 days. qRT-PCR demonstrated
that 3 mM CHIR alone induced expression of PAX3 slightly more
than MSX1 compared with expansion conditions (3 mM CHIR
plus 0.5 mM PMA; Figure 2A). When the concentration of CHIR
was reduced from 3 mM to 1.5 mM, MSX1 and PAX3 were
downregulated by about the same amount (Figure 2A). When
neural epithelial cells were cultured with PMA alone, MSX1 and
PAX3 were down-regulated compared to expansion conditions. In
addition, PMA alone resulted in increased the expression of NKX6-
1, NKX2-1, OLIG2, and FOXA2 compared to expansion conditions
(Figure 2A). Of interest, we found that expression of the neural
progenitor marker SOX1 increased in cultures treated with only
PMA compared to cultures grown under expansion conditions
(Figure 2A). These results are consistent with the developmental
roles of WNT and SHH signaling [12,19].
To confirm the qRT-PCR results, we performed immunostain-
ing on neural epithelial cells cultured for 6 days with PMA, CHIR,
or both. PMA alone resulted in decreased PAX3 expression as well
as increased expression of NKX6.1, NKX2.2, and FOXA2
compared to expansion conditions as well as CHIR alone
(Figure 2B). In addition, more cells expressed NKX6.1,
NKX2.2, and FOXA2 at 1 mM PMA compared to 0.5 mM
PMA. In contrast, fewer PAX3-positive cells were observed at
1 mM PMA than at 0.5 mM PMA. There was increased SOX1-
staining intensity in cells treated with only PMA compared to cells
cultivated under expansion conditions (Figure 2B). More cells were
SOX1-positive with PMA compared to cells treated with CHIR
alone (Figure 2B). These data are consistent with the qRT-PCR
results and suggest that cultures of neural epithelial cells can be
directed to differentiate into ventral neural tube- and neural crest-
derived lineages using CHIR and PMA, respectively. However,
these differences may reflect different subpopulations within the
culture. Experiments below discriminate between these alterna-
tives.
Next, we sought to determine if expression of markers of
rostrocaudal identity by cultures of neural epithelial cells could be
modulated by developmental factors. Retinoids are produced
in vivo by somites and specify spinal cord fate, which can be
mimicked in vitro with all-trans retinoic acid (RA) [20]. Neural
epithelial cells at passage 20 treated with RA for 1 or 8 days
exhibited lower levels of HOXA2 and increased levels of HOXA4,
HOXB4, but not HOXA9 (Figure 2C). Therefore, RA directs
cultures of neural epithelial cells to express caudal patterning
markers, consistent with the role of retinoids during embryonic
development. In contrast, under none of the tested conditions were
forebrain markers, such as FOXG1, induced, suggesting that neural
epithelial cells are committed to expressing markers of caudal
fates, consistent with the role of WNT factors in caudal fate
specification.
Directed Differentiation of Neural Epithelial Cells into
Neural Crest Lineages: Peripheral Neurons and
Mesenchymal Cells
When cultured with only CHIR, cultures of neural epithelial
cells expressed markers that might indicate potential to differen-
Human Small Molecule-Expanded Neural Progenitors
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Figure 1. Derivation of neural epithelial cells. (A) Plated EBs differentiating in the presence of both PMA and CHIR for 6 days. (B) Phase-contrast
images of neural epithelial cells on the indicated days after splitting. (C) Immunostaining of hESC-derived neural epithelial cells with antibodies raised
against the indicated neural progenitor markers. Nuclei are counterstained with Hoechst. (D) Immunostaining of spontaneously differentiated neural
epithelial cells for TUBBIII and NEUN, for GFAP and S100-beta after astrocyte differentiation, as well as O4 and OLIG2 after spontaneous
differentiation, indicating oligodendrocyte formation. Scale bars are 100 mm. See also Figure S1.
doi:10.1371/journal.pone.0059252.g001
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tiate into neural crest cells. For this reason, we tested the ability of
neural epithelial cells to differentiate into neural crest cells, by
culturing cells at passages 15–25 in the presence of CHIR for 2
days followed by BMP4 without CHIR or 10% fetal calf serum
(FCS; Figure 3A). After four days, cells exhibited upregulation of
PAX7, SLUG, and the neural crest surface marker HNK-1, but
downregulation of PAX6 (Figures 3B and C). qRT-PCR
demonstrated that PAX7, SOX9 and TFAP2A were induced by
BMP4 (Figure S6A). Immunostaining showed that 2 days of CHIR
and BMP4 induced expression of TFAP2A (Figure S6B). This
combination of markers is consistent with neural crest progenitors.
After maturation for two weeks, we observed greater than 80%
of neurons expressed PERIPHERIN (Figure 3D). Some of the
PERIPHERIN-positive neurons expressed the neural crest marker
TFAP2A (Figure S5C). Immunostaining and confocal microscopy
demonstrated that a subset of cells expressed both PERIPHERIN
and BRN3A, which is a combination that specifically marks PNS
sensory neurons (Figure 3D and Figure S6D). After differentiation
and maturation, qRT-PCR analyses confirmed that peripheral
sensory neuron markers PERIPHERIN and BRN3A were upregu-
lated by BMP4 (Figure 3E). As expected, 8 days of treatment with
PMA instead of BMP4 essentially abolished expression of these
markers (Figure 3F). Overall, the efficiency of directing differen-
tiation of neural epithelial cells into PERIPHERIN and TUBBIII
double-positive cells was about 40 to 50% (Figure 3F). We
conclude that cultures of neural epithelial cells are capable of
forming cells expressing markers of peripheral neurons, including
sensory neurons.
Neural crest cells can form non-neural cells including mesen-
chymal cells. To test whether neural epithelial cells can also form
non-neural cells, the cells at passages 20–25 were differentiated
using first CHIR only for 2 days and then serum-containing
medium for 14–21 days (Figure 3A). Under these conditions, we
observed the formation of mesenchymal cells that could be
cultured for more than 10 passages and resembled primary human
fibroblasts. Human fibroblasts, which are mesenchymal cells, as
well as the differentiated mesenchymal cells expressed the markers
VIMENTIN, CD9, SMA, NESTIN, and alkaline phosphatase
(Figure S6E). Expression of SMA and alkaline phosphatase may
indicate spontaneous differentiation of cells into smooth muscle
and osteoblastic cells. Finally, using mesenchymal stem cell
protocols, we were able to differentiate the neural epithelial cell–
derived mesenchymal cells into cells expressing markers of
adipocytes and osteocytes (Figure S6F). Based on these data, we
conclude that cultures of neural epithelial cells are capable of
forming cells expressing markers of peripheral neurons as well as
mesenchymal neural crest cell derivatives.
Directed Differentiation of Neural Epithelial Cells into
Ventral Neural Tube Lineages: mDANs and MNs
When cultured with only PMA, cultures of neural epithelial cells
expressed markers that might indicate potential to differentiate
into ventral neural tube cell lineages. For this reason, we tested the
ability of neural epithelial cells to differentiate into mDANs and
MNs, which are derived from ventral neural tube progenitors
in vivo. First, we exposed neural epithelial cells at passages 15–25 to
PMA and FGF8 for 8 days (Figure 4A), which specify formation of
ventral midbrain cells including mDANs [21]. After maturation
for 2 weeks, immunostaining of neural epithelial cells demonstrat-
ed that a large proportion had differentiated into TH-, FOXA2-,
and TUBBIII-positive neurons, an expression pattern that
specifically marks mDANs (Figures 4B and C). qRT-PCR showed
upregulation of markers of mDAN differentiation, including EN-1,
LMX1A, LMX1B, NURR1, FOXA2, and AADC (Figure 4D). The
overall efficiency (up to ,35% of total cells and up to 70% of
neurons) of differentiation of neural epithelial cells into cells
expressing markers of mDAN identity was consistent among 3
different neural epithelial cell cultures at multiple different passage
numbers from three different pluripotent stem cell lines (Figure 4E).
Thus, cultures of neural epithelial cells have the potential to
differentiate into cells expressing markers indicative of mDAN
identity.
SHH and RA signaling in combination specify the formation of
MNs [22]. As the expression of markers of neural fate by neural
epithelial cells is modulated by both SHH and RA, we asked
whether both factors together can direct differentiation along the
MN lineage. Neural epithelial cells at passages 15–25 were treated
for 2 days with 1 mM PMA and then for 8 days with 1 mM PMA
and 1 mM RA to induce ventralization and caudalization, with
subsequent maturation for 2 weeks without PMA or RA
(Figure 5A). Immunostaining of the cells demonstrated the
presence of ISLET1 and CHAT double-positive cells that also
expressed MAP2 and SMI32, consistent with MN identity
(Figures 5B and C). MN identity is supported by the presence of
HB9 and TUBBIII double-positive cells (immunostaining, see
Figure 5D). qRT-PCR analysis showed significant upregulation of
markers of MN differentiation including HB9, ISLET1, CHAT,
and HOXB4 (qRT-PCR, see Figure 5E). Counting of single cells
after maturation showed that neural epithelial cells formed cells
expressing markers of MN identity with an efficiency of
approximately 50% (Figure 5F).
Cultures of Neural Epithelial Cells Contain Multipotent
Stem Cells Capable of Forming both Neural Tube and
Neural Crest Cell Lineages
Although these results indicate that cultures of neural epithelial
cells have the potential to differentiate into both neural crest and
neural tube cell derivates, it is possible that these derivatives arise
from multiple subpopulations of cells in these cultures separately
committed to either neural tube or neural crest cell fates. We
therefore asked whether single neural epithelial cells are multi-
potent and capable of forming both neural tube and neural crest
cell lineages. To answer this question, we generated 3 clonal
neural epithelial cells lines from a single hESC-derived culture of
neural epithelial cells (Figure S7A). These clonal lines expressed
the neural progenitor makers NESTIN, SOX2, SOX1, and PAX6
(Figure S7B). Each of these three lines could be differentiated into
mDANs, MNs, and PNS neurons (Figure S7C). Finally, we
demonstrated that each of these three lines could be directed to
differentiate into cells expressing markers of astrocytes and
olidodendrocytes (Figure S7D). Therefore, we concluded that
cultures of neural epithelial cells contain cells that self-renew and
are competent to differentiate into cells expressing markers
consistent with caudal derivatives of both neural tube and neural
Figure 2. Neural epithelial cells can be respecified along both the dorsoventral and rostrocaudal axes. (A) qRT-PCR analysis for the
indicated marker on neural epithelial cells cultured under the indicated conditions for 6 days. Error bars represent the standard deviation from 3
independent cultures. (B) Immunostaining of neural epithelial cells cultured with the indicated concentration of PMA or CHIR for 6 days for PAX3,
NKX2.2, NKX6.1, FOXA2, and SOX1. (C) qRT-PCR analysis of neural epithelial cells cultured with 1 mM RA for 1 or 8 days for the indicated rostrocaudal
marker. Error bars represent the variation from 2 independent cultures. Scale bars are 100 mm. See also Figure S3.
doi:10.1371/journal.pone.0059252.g002
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Figure 3. Differentiation of PNS neurons and mesenchymal cells from neural epithelial cells. (A) Summary of isolation and differentiation
protocol used in this study. (B) Immunostaining of differentiated neural epithelial cells for HNK-1. (C) Neural epithelial cells were treated with CHIR for
2 days and then switched to BMP4 or serum-containing medium for 2 additional days. In both cases, the cultures show cells positive for the neural
plate border/neural crest markers PAX7 and SLUG, whereas only some cells are still positive for PAX6. (D) Immunostaining of smNPCs differentiating
in the presence of BMP4 for PERIPHERIN and BRN3A. (E) qRT-PCR demonstrating the upregulation of PERIPHERIN and BRN3A in neural epithelial cells
differentiated for 8 days in the presence of BMP4, but not PMA, following two weeks of maturation. (F) More than 40% of cells are double positive for
PERIPHERIN and TUBBIII after patterning with BMP4 and maturation. Error bars represent variation from 2 independent cultures. Scale bars are
100 mm. CHIR =CHIR99021, DM=dorsomorphin, FCS = fetal calf serum, PMA=purmorphamine, and SB= SB43152.
doi:10.1371/journal.pone.0059252.g003
Figure 4. Directed differentiation of neural epithelial cells into mDANs. (A) Summary of isolation and differentiation protocol used in this
study. (B) hESC-derived neural epithelial cells were differentiated into mDANs and immunostained for TH and FOXA2 and counterstained for nuclei
with Hoechst. (C) Immunostaining of neural epithelial cell–derived mDANs for TH and TUBIII and counterstained for nuclei with Hoechst. (D) qRT-PCR
analysis of neural epithelial cell–derived cultures for the indicated markers of mDAN specification on day 21. Error bars show standard deviation from
3 different experiments. (E) Efficiency of mDAN formation for 3 independent neural epithelial cell lines. Error bars represent the variation between 2
independent cultures. Scale bars are 100 mm. CHIR = CHIR99021, DM=dorsomorphin, PMA=purmorphamine, and SB= SB43152.
doi:10.1371/journal.pone.0059252.g004
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crest cells. Because of their differentiation capacity as well as their
ability to self-renew with only small molecules, we termed these
cells small molecule neural progenitor cells (smNPCs).
Neurons Formed from smNPCs are Electrophysiologically
Functional, Integrate and Mature in vivo
Our next objective was to evaluate the electrophysiological
function of smNPC-derived mDANs using patch clamping after
two weeks of maturation. Stepping the membrane holding
potential from 270 to +20 mV with 10 mV increments elicited
a fast-activating, fast-inactivating inward current followed by
a slower activating, slowly deactivating outward current (Fig-
ure 6A). The I–V curves of both currents are typical for sodium
inward and potassium outward currents through voltage-gated
channels (Figure 6B) [23,24]. Current-clamp recordings demon-
strated the presence of neurons that spontaneously fired action
Figure 5. Directed differentiation of neural epithelial cells into MNs. (A) Summary of isolation and differentiation protocol used in this study.
(B) hESC-derived neural epithelial cells were differentiated into MNs and immunostained for ISLET1, CHAT, and MAP2 and counterstained for nuclei
with Hoechst. (C) Immunostaining showing colocalization of ISLET1, SMI32 and CHAT. (D) Immunostaining of neural epithelial cell–derived MNs
showing colocalization of HB9 and TUBIII. (E) qRT-PCR analysis of neural epithelial cell–derived cultures for the indicated markers of MN specification
on day 21 of differentiation. Error bars show standard deviation of 2 independent experiments. (F) MN differentiation efficiency from neural epithelial
cells was approximately 50% as determined by TUBBIII and HB9 colocalization. Error bars represent variation from 3 independent cultures. Scale bars
are 100mm. CHIR= CHIR99021, DM=dorsomorphin, PMA=purmorphamine, RA= all-trans retinoic acid, and SB= SB43152.
doi:10.1371/journal.pone.0059252.g005
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potentials (APs) with frequencies of up to 2.1 Hz (mean
1.0060.28 Hz, n= 12; Figure 6C). One critical test of neuronal
identity is whether smNPC-derived neurons can form functional
synaptic connections using spontaneous miniature events [25]. To
this end, we used an in voltage clamp whole-cell configuration
with a holding potential of 270 mV and with a frequency
0.3560.11 Hz. The average amplitude of miniature spontaneous
postsynaptic currents was 21.1862.47 pA (peak value; n= 7 cells,
360 events analyzed). Representative trace and offline analysis
results are shown in Figure S8A– F. The offline analysis revealed
that recorded miniature spontaneous postsynaptic currents have
the amplitude or kinetic parameters comparable to those of
human neurons [26,27,28]. These results demonstrate that
smNPC-derived neurons have acquired the electrical properties
of excitable neurons and developed synaptic contacts between
neurons.
Our final test was to evaluate the survival and differentiation
potential of smNPCs in vivo. 1.56105 smNPCs and smNPCs
differentiated with PMA and FGF8 for 8 days were stereotactically
transplanted into the midbrain of adult mice. Two weeks and eight
weeks after transplantation, transplanted cells were identifiable
with species-specific antibodies against human Nuclei and human
NCAM (Figure 6D–H and Figures S9A–F). In vivo neuronal
differentiation of smNPCs was detectable by hNuclei/DCX
double positive as well as hNuclei/TUBBIII double-positive
immunostainings (Figures 6D and E and Figure S9B and C).
Furthermore, the grafted cells differentiated and expressed mature
neuronal markers indicated by the lack of SOX2 and hNuclei
double-positive cells and the presence of hNCAM and SYNAP-
TOPHYSIN as well as of hNCAM and NeuN double-positive cells
(Figures 6F, 6G and S9). Only when smNPCs were pre-
differentiated with PMA and FGF8 and transplanted into the
substantia nigra, did they continue to differentiate towards the
dopaminergic subtype in vivo, as demonstrated by the presence of
TH and FOXA2 double-positive cells (Figures 6H and S9F).
Therefore, smNPCs are capable of differentiating into neurons,
including dopaminergic neurons, in vivo after transplantation.
smNPCs were also derived from iPSCs. iPSC-derived smNPCs
expressed similar markers and had the same differentiation
potential as hESC-derived smNPCs (Figure S10).
smNPC-derived mDANs with LRRK2 G2019S are
Susceptible to Degeneration
Next, we assessed the ability of smNPCs to recapitulate
neurodegeneration-associated pathology in vitro. For this experi-
ment, smNPCs were derived from iPSCs generated from patients
with PD carrying the mutation LRRK2 G2019S as well as from
age- and gender-matched controls. These smNPCs were then
matured into cultures of mDANs for two weeks. First, we
determined the affects of oxidative stress by culturing replated
neurons in N2 medium alone to eliminate the antioxidants present
in the B27 supplement and the neurotrophins used in the standard
culture medium. After 48 hours, we observed an increase of 37%
in cultures with LRRK2 G2019S in the number of TH and cleaved
CASPASE3 double-positive cells, which marks dopaminergic
neurons undergoing apoptosis (Figure 7 and Figure S11). Addition
of 6-hydroxydopamine or rotenone resulted in a significant
increase in the number of TH and cleaved CASPASE3 double-
positive cells (Figure 7 and Figure S11). These results are in
agreement with the previously published phenotype [3]. Under all
stressing conditions, more than 80% of the cells that were cleaved
CASPASE3-positive also expressed TH (Figure S12). Therefore,
apoptosis is preferentially induced in mDA neurons under the
tested conditions. However, in contrast to the previous publica-
tion, this protocol is rapid, efficient, uses robustly expandable cells,
and involves no manual manipulation. These characteristics
should make smNPC-derived disease models more easily amena-
ble to HTS compared to previous cell types.
Discussion
HTS on stem cell-based phenotypic assays have the potential to
discover revolutionary new drugs to treat neurodegenerative
diseases. However, the scale of HTS campaigns requires a source
of cells capable of robust and immortal expansion without costly
growth factors or cumbersome manual steps. In addition, the cell
source needs to be able to efficiently differentiate into lineages such
as MNs and mDANs for disease modeling. Here, we have
demonstrated that smNPCs possess these properties (Table 1 and
Figure 8). No other reported cell type such as NSCs, lt-hESNSCs,
pNSCs, R-NCs or even direct differentiation of hPSCs can meet
these requirements. Although one report demonstrates the use of
NSCs derived from hESCs for HTS, it is interesting to note that
the screen was for small molecules that were selectively toxic to
cells that were not dopaminergic neurons [29]. While this does,
indeed, establish proof-of-principle for HTS using human NSCs,
we argue that using inefficient differentiation protocols together
with chemicals that are toxic to most of the resulting cells is likely
to introduce many artifacts and is clearly not an optimal approach.
The relationship of cell types derived in vitro such as lt-hESNSCs
and pNSCs, with specific cell populations in developing embryos is
of significant interest [13]. Unfortunately, such a comparison is not
possible at present because data directly comparing the gene
expression of specific embryonic cell populations with cells
generated in vitro is lacking. Nevertheless, it is possible to speculate
about the order of these cells based upon their reported
differentiation potential. Pluripotent stem cells, of course, have
the greatest differentiation potential of any cell type than can be
cultured in vitro. Next, smNPCs and R-NCs have the competence
to form both neural tube and neural crest lineages. In contrast,
pNSCs are restricted to the CNS and unable to differentiate into
PERIPHERIN-positive neurons [7]. However, pNSCs are able to
efficiently form both mDANs and MNs. Finally, NSCs are
restricted to the CNS and are unable to efficiently form mDANs
and MNs. Although the differentiation potential of lt-hESNSCs for
neural crest has not been robustly tested, treatment of lt-hESNSCs
with BMP4 after pre-treatment with valproic acid and 59-aza-29-
deoxycytidine resulted in only 5% of cells expressed PAX3 [30].
This strongly suggests that lt-hESNSCs are restricted to CNS fates.
Like NSCs, they require FGF2 and EGF for self-renewal, and their
ability to form mDANs and MNs is significantly reduced
compared to pNSCs. For these reasons, we would order the cell
types with decreasing differentiation potential as follows:
hPSCs.smNPCs and R-NCs .pNSCs.lt-hESNSCs.NSCs.
Materials and Methods
Ethics Statement
Informed consent was obtained for all patients donating samples
to this study prior to the donation using a written form and
protocol that was prior approved by the instutional review board:
Ethik-Kommission der Medizinischen Fakulta¨t am Universita¨tsk-
linikum Tu¨bingen. All experiments involving animals (e.g. cell
transplantation) were carried out in accordance with local
institutional guidelines under the protocol 87-51.04.2011.A057,
which was approved by Landesamt fu¨r Natur, Umwelt und
Verbraucherschutz of the state of North Rhine-Westphalia,
Germany. In vitro experiments were carried out with existing cell
Human Small Molecule-Expanded Neural Progenitors
PLOS ONE | www.plosone.org 10 March 2013 | Volume 8 | Issue 3 | e59252
lines obtained from previous studies except where noted below.
The appropriate citations are given next to each cell line in the
Materials and Methods.
Generation of iPSCs
The iPSCs used in this study were newly generated. Informed
consent was obtained from all patients involved in our study prior
to cell donation as described in the ethics section above. Dermal
fibroblasts, obtained from skin biopsies of patients with PD and
healthy controls, were cultured in fibroblast medium, which
consisted of DMEM supplemented with 10% fetal calf serum, 1%
penicillin/streptomycin/glutamine, 1% nonessential amino acids,
1% sodium pyruvate (all PAA), and 0.5 mM beta-mercaptoetha-
nol (Invitrogen).
The reprogramming of human dermal fibroblasts was adapted
from Takahashi et alia [1]. Retroviral vectors containing OCT4
(Addgene 17217), SOX2 (Addgene 17218), KLF4 (Addgene 17219),
and, when indicated, c-MYC (Addgene 17220) were co-transfected
using Fugene 6 (Roche) into 293 T cells (purchased from ATCC)
together with the appropriate packaging plasmids (Addgene 8454
Figure 6. smNPCs-derived neurons become electrophysiologically mature and mature in vivo. (A) On average, the recorded membrane
potential from smNPC-derived neurons was 23562 mV (n= 12) and the cell membrane capacitance was 31.8864.36 pF (n = 12). These values are
consistent with previously published results of neurons differentiated from human stem cells [34,35,36]. The net of transmembrane currents, elicited
by the voltage steps from holding potential 270 mV to +20 mV with 10 mV increments (the above panel shows the stimulation paradigm). (B)
Current-voltage relationship of inward and outward currents, measured on the peak and normalized to cell capacitance (n = 8). (C) Cells demonstrate
spontaneous firing of action potentials (APs) like neurons. Right panel shows more detailed view on the unitary action APs. See also Figure S8 for
additional data and recording of miniature potentials. (D)–(H) smNPCs integrate and mature in vivo. Transplanted human cells were identified using
human Nuclei (hNuclei)- and human NCAM (hNCAM)- specific antibodies. (D) Two weeks after transplantation into the midbrain of immunodeficient
mice, smNPCs differentiated into DCX-positive and TUBBIII (E) neurons. (F) Two weeks post transplantation, smNPC are negative for SOX2. (G) smNPCs
form synapses already two weeks post transplantation, as shown by SYNAPTOPHYSIN and hNCAM staining. (H) Only after treatment with PMA and
FGF8 for 8 days before transplantation did TH+ neurons form. For further analysis and long-term survival after eight weeks, see Figure S9.
doi:10.1371/journal.pone.0059252.g006
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Figure 7. smNPCs are suitable for modeling of neurological diseases such as LRRK2 G2019S induced Parkinson’s Disease. Patient-
specific human iPSCs from two patients with Parkinson’s disease harboring LRRK2 G2019S were differentiated in parallel with two lines derived from
healthy age- and sex-matched control donors. After two weeks of maturation, the cultures were replated as single cells. Medium was switched to N2
medium or N2 medium supplemented with 5 mM 6-OHDA, or 10 mM 6-OHDA, or 100 nM Rotenone to induce additional cytotoxic stress. Apoptosis
was assessed by double-staining for TH and cleaved CASPASE3 (CASP) in duplicate wells for each line and concentration. (A) Example picture showing
TH+/CASP3- (empty arrowhead) and TH+/CASP3+ neurons (arrowhead). (B) When normalized to the average number of apoptotic cells detected in
the wild-type cultures, 6-OHDA and rotenone lead to a higher cell death, with an even higher increase in cells carrying LRRK2 G2019S. Error bars
represent the variation from duplicate wells. (C) When normalizing each concentration to the average apoptosis in TH+ neurons from healthy
controls, an increase of 46% can be observed in LRRK2 G2019S over wild type cultures in all stressor concentrations used. Error bars represent S.D. ***
indicates p,0.001, according to Student’s t-test. See also Figure S11 for primary, unnormalized data.
doi:10.1371/journal.pone.0059252.g007
Figure 8. Summary of smNPCs. Diagram illustrating the conditions used to derive, propagate, and differentiate smNPCs. CHIR = 99021,
DM=dorsomorphin, FCS = fetal calf serum, PMA=purmorphamine, RA= all-trans retinoic acid, and SB= SB43152.
doi:10.1371/journal.pone.0059252.g008
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and 8449). After 48 hours, supernatants containing viral particles
were applied to the patients’ fibroblasts in the presence of 6 mg/
mL protamine sulphate (Sigma Aldrich). Two to four infections
were performed for each fibroblast sample. One day later,
fibroblasts were reseeded on mouse embryo fibroblast (MEF)
feeder cells or on gelatin-coated cell culture dishes. The mouse
embryonic fibroblasts (MEFs) used in this study were derived in
the laboratory of Prof. Dr. Hans Scho¨ler and have been reported
previously [31]. The following day, hESC medium supplemented
with 1 mM valproic acid (Sigma Aldrich) was added, and the
culture medium was changed daily thereafter. After 10–14 days,
iPSC-like colonies were observed and valproic acid was discon-
tinued. Individual colonies were isolated and clonally expanded. In
total, two iPSC lines, designated Control 1 and Control 2, were
derived from healthy patients and two iPSC lines, designated
LRRK2 1 and LRRK2 2, were derived from patients with PD
harboring the mutation G2019S.
Pluripotent Stem Cell Culture
The human ESC line HUES6 was used in this study and was
purchased from the hESC Collection (Harvard University). The
derivation of this line has been reported previously [32]. HUES6
and iPSCs were cultured on a layer of mitotically inactivated (with
mitomycin C (Tocris)) mouse embryo fibroblasts (MEFs) in hESC
medium. The mouse embryonic fibroblasts (MEFs) used in this
study were derived in the laboratory of Prof. Dr. Hans Scho¨ler and
have been reported previously [31]. hESC medium consisted of
Knockout DMEM (Invitrogen) with 20% Knockout Serum
Replacement (Invitrogen), 1 mM beta-mercaptoethanol (Invitro-
gen), 1% nonessential amino acids (NEAA, Invitrogen), 1%
penicillin/streptomycin/glutamine (PAA), freshly supplemented
with 5 ng/mL FGF2 (Peprotech). Pluripotent stem cells were split
1:5 to 1:8 every 5–7 days. Colonies were mechanically
disaggregated with 1 mg/mL collagenase IV (Invitrogen). 10 mM
ROCK Inhibitor (Ascent Scientific) was added for 24 hours after
splitting.
smNPC Derivation
For generation of smNPCs from pluripotent stem cells, colonies
were detached from the MEFs 3–4 days after splitting, using
2 mg/mL collagenase IV. Pieces of colonies were collected by
sedimentation and resuspended in hESC medium (without FGF2)
supplemented with 10 mM SB-431542 (Ascent Scientific), 1 mM
dorsomorphin (Tocris) for neural induction, as well as 3 mM
CHIR 99021 (Axon Medchem) and 0.5 mM PMA (Alexis), and
cultured in petri dishes. Medium was replaced on day 2 by N2B27
medium supplemented with the same small molecule supplements.
N2B27 medium consisted of DMEM-F12 (Invitrogen)/Neurobasal
(Invitrogen) 50:50 with 1:200 N2 supplement (Invitrogen), 1:100
B27 supplement lacking vitamin A (Invitrogen) with 1% penicil-
lin/streptomycin/glutamine (PAA). On day 4, SB-431542 and
dorsomorphin were withdrawn and 150 mM Ascorbic Acid (AA;
Sigma) was added to the medium. On day 6, the EBs, which
showed intensive neuroepithelial outgrowth, were triturated with
a 1,000 mL pipette into smaller pieces and plated on Matrigel-
coated (Matrigel, growth factor reduced, high concentration; BD
Biosciences) 12-well plates at a density of about 10–15 per well in
smNPC expansion medium (N2B27 with CHIR, PMA, and AA).
For coating, Matrigel was diluted to a final dilution of 1:100 in
Knockout DMEM (Invitrogen) prior to coating 500 mL per well of
a 12-ell plate overnight. Coated plates were wrapped with parafilm
and kept in the fridge for up to 1 month. The first split was
performed at a 1:5 to 1:10 ratio on days 2 to 4 after plating. All the
remaining splitting ratios were at least 1:10. The higher splitting
ratios selected better for smNPC colonies and led to a high purity
with fewer splits. After a maximum of 5 splits, cultures were
virtually free of contaminating non-smNPCs.
smNPC Culture
smNPC were cultured on Matrigel-coated 12-well (Nunc) cell-
culture plates. smNPC expansion medium consisted of N2B27
freshly supplemented with CHIR, PMA, and AA, with a medium
change every other day. Typically, cells were split 1:10 to 1:15
every 5 or 6 days. For splitting, cells were digested into single cells
for about 15 minutes at 37uC with prewarmed accutase (PAA).
Cells were diluted in DMEM (PAA) for centrifugation at 2006g
for 5 minutes. The cell pellet was resuspended in fresh smNPC
expansion medium and plated on Matrigel-coated cell culture
dishes.
Differentiation of smNPCs
All differentiation experiments were conducted with smNPCs of
passage 13 and above. For undirected differentiation, including
neurons, astrocytes and oligodendrocytes, it was sufficient to
change smNPC expansion medium to N2B27 medium without
supplements. For obtaining more homogenously plated cultures,
cells were digested to single cells with Accutase after two weeks of
differentiation, replated on fresh matrigel-coated plates and
further differentiated for at least one week. For better survival,
50 mM dbcAMP (Sigma Aldrich) was added after replating.
For generation of more ventral CNS neurons, including
mDANs, smNPC expansion medium was changed 2 days after
splitting to N2B27 medium with 100 ng/mL FGF8 (Peprotech),
1 mM PMA, and 200 mM AA. After 8 days in this medium,
maturation medium–N2B27 with 10 ng/mL BDNF (Peprotech),
10 ng/mL GDNF (Peprotech), 1 ng/mL TGF-b3 (Peprotech),
200 mM AA, and 500 mM dbcAMP–was used for the maturation
of neurons. 0.5 mM PMA was added to this medium for 2 more
days. One day after changing to maturation medium, the cultures
were split at a 1:3 ratio as small clumps, or single cells after
Accutase treatment, or earlier when cultures became over-
confluent. Cultures were analyzed after 2 weeks in maturation
conditions unless otherwise indicated.
For induction of posterior cells, including MNs, smNPC
expansion medium was changed to N2B27 with 1 mM PMA 3
days after splitting. Two days later, 1 mM retinoic acid (RA,
Sigma) and 1 mM PMA were added for 8 days. Following one day
in maturation medium (N2B27 with BDNF, GDNF, and
dbcAMP), cultures were also split as clumps or single cells after
Accutase treatment at a ratio of 1:2 to 1:3. Cells were cultured in
maturation medium for 2 weeks.
For generation of PNS neurons, smNPCs 2 days after splitting
were switched to N2B27 with only CHIR for 2 days. Afterward,
10 ng/mL BMP4 (R&D Systems) was added for 8 days. Splitting
and maturation was performed as described for the generation of
MNs.
For directed astrocyte differentiation, smNPCs were cultured
with 10 ng/ml FGF2 and 10 ng/ml EGF (Peprotech) for 2 days
and later switched to N2 medium with 4% FCS (PAA)
supplemented with 10 ng/ml CNTF (Peprotech) for at least 2
weeks. Cultures were split using accutase when confluent and
replated on fresh Matrigel-coated plates. After withdrawal of
CNTF, cells were treated with 500 mM dbcAMP in N2 medium
with 4% FCS for at least one week, or could be expanded for
several weeks in 4% FCS containing N2 medium using 10 ng/ml
EGF before being treated with dbcAMP. After dbcAMP
treatment, cells were kept in 4% FCS in N2 for at least one more
week.
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For mesenchymal neural crest differentiation, smNPCs were
cultured with CHIR only for 2 days after splitting and sub-
sequently changed to DMEM (PAA) with 10% FCS and 1%
penicillin/streptomycin/glutamine. Cultures were split at a 1:3
ratio when confluent using trypsin (Invitrogen) and cultured on cell
culture–treated plastic dishes. Mesenchymal cells derived from
smNPCs were differentiated into osteocytes and adipocytes for 14
days, using the Human MSC Functional Identification Kit (R&D
Systems). The supplied reagents were used according to the
manufacturer’s instructions.
Cytotoxicity Experiments
For assessing sensitivity for cytotoxicity of wild type or LRRK2
G2019S mDANs, patient-specific iPSC – derived smNPCs at
passage 15 were differentiated as mentioned above. All splitting
procedures were performed as single cells using Accutase
treatment. After 14 days of differentiation, mDAN cultures were
digested to single cells using Accutase and reseeded in maturation
medium on Matrigel-coated 48well or 96well plates (Nunc) at
70,000 or 35,000 cells per well. Two days later, medium was
changed against N2 medium (DMEM/F12 with 1% N2 supple-
ment and 1% penicillin/streptomycin/glutamine) for six hours to
remove antioxidants and enzymes present in B27 supplement.
Medium was changed against fresh N2 medium or N2 medium
supplemented with 5 mM 6-OHDA, or 10 mM 6-OHDA (Tocris),
or 100 nM Rotenone (Sigma). Two days later, cells were fixed and
stained for TH and cleaved CASPASE3, as mentioned below.
Transplantation
For analyzing the in vivo differentiation potential of smNPCs,
smNPC and mDAN progenitors were transplanted into the
midbrain of male NOD.CB17-Prkdcscid/NCrHsd mice (purchased
from Harlan; 8 weeks, ,25 g). The latter were differentiated
towards mDANs for 8 days as described previously. Before
transplantation, the cells were dissociated to single cells for about
15 minutes at 37uC with pre-warmed accutase and resuspended in
medium at a density of 56104 cells per microliter. For
stereotactical transplantation, animals were deeply anesthetized
by intraperitoneal injection of 0.017 ml of 2.5% Avertin per gram
of body weight and positioned into a stereotatic frame (David Kopf
Instruments, model 940). Injection of 3 ml of the cell suspension
was performed using a Hamilton 7005KH 5 ml syringe. Franklin
& Paxinos mouse brain atlas was consulted for assessing the
stereotactic coordinates of the midbrain in relation to bregma
(anteroposterior: 23 mm, mediolateral: 61,5 mm, dorsoventral:
24,4 mm below skull).
Immunocytochemistry
For confocal microscopy, cells were plated on Matrigel-coated
glass coverslips. Cultures were fixed for 20 minutes with 4%
paraformaldehyde (Electron Microscopy Sciences) in PBS (In-
vitrogen) and washed twice with PBS. Permeabilization and
blocking was done in one step using 0.1% Triton X-100 (Sigma
Aldrich), 10% FCS, and 1% BSA in PBS for 45 minutes. Plates or
coverslips were washed once with 0.1% BSA in PBS and the
primary antibodies were applied overnight at 4uC in 1% BSA in
PBS. The next day, following one washing step with 0.1% BSA in
PBS, secondary antibodies were applied for one hour at room
temperature in 1% BSA in PBS. Finally, cells were washed three
times with 0.1% BSA in PBS-T (0.05% Tween-20), including
a Hoechst counterstaining for nuclei in the second washing step.
Cells were mounted in Vectashield mounting medium (Vector
Labs) and imaged on a Zeiss PALM/Axiovert fluorescence
microscope or a Zeiss LSM700 confocal microscope. If necessary,
images were merged using ImageJ and Adobe Photoshop.
To determine the efficiency of differentiation into specific
neurons, after 2 weeks in maturation medium, cells were
disaggregated and seeded at a density of 56104 cells per well in
maturation medium on Matrigel-coated 48-well plates. The next
day, the cells were fixed and stained, as mentioned above. Cell
counting and evaluation of the differentiation efficiency was
performed using Cellomics ArrayScan high content imager with
the supplied software. 25 fields were taken from each well with
a 10X magnification, and the total number of cells was determined
by counting the Hoechst-positive nuclei. Three independently
differentiated cultures were evaluated for each iPSC line. MN
cultures were counted manually from 5 randomly taken pictures at
10X magnification from each well.
The primary antibodies used in this study are mouse anti-
NESTIN (1:150, R&D), goat anti-SOX1 (1:150, R&D), rabbit
anti-PAX6 (1:300, Covance), goat anti-SOX2 (1:200, Santa Cruz),
mouse anti-FOXA2 (1:100, Santa Cruz), rabbit anti-TH (1:500,
Pel Freez), sheep anti-TH (1:400, Pel Freez), mouse anti-TUBBIII
(1:1000, Covance), rabbit anti-TUBBIII (1:2000, Covance), rabbit
anti-MAP2 (1:1000, Santa Cruz), mouse anti-O4 (1:100, Milli-
pore), rabbit anti-ISLET1 (1:1500, Abcam), mouse anti-HB9
(5 mg/mL own preparation from DSHB hybridoma), goat anti-
CHAT (1:100, Millipore), mouse anti-BRN3A (1:500, Santa
Cruz), rabbit anti-PERIPHERIN (1:200, Millipore), rabbit anti-
GFAP (1:1000, Dako), mouse anti GFAP (1:500, Millipore), mouse
anti S100-beta (1:100, Thermo), mouse anti-SMA (1:150, Dako),
goat anti-T (1.200, Santa Cruz), mouse anti-Vimentin (1:150,
Dako), rabbit anti-CD9 (1.100, Santa Cruz), mouse anti-PAX7
(1:100, Neuromics), mouse anti-SLUG (1:100, Millipore), mouse
anti-OSTEOCALCIN (R&D Systems, 5 mg/mL), goat anti-
FABP4 (R&D Systems, 5 mg/mL) mouse anti-FORSE 1 (DSHB,
10 mg/mL), mouse anti-PAX3 (DSHB, 5 mg/mL), mouse anti-
NKX2.2 (DSHB, 5 mg/mL), mouse anti-NKX6.1 (DSHB, 5 mg/
mL), mouse anti TFAP2A (DSHB, 2 mg/mL), rabbit anti cleaved
CASPASE3 (1:1000, CellSignaling). All secondary antibodies were
obtained from Invitrogen and were conjugated to AlexaFluor
fluorochromes. Alkaline phosphatase activity was detected using
FastRed and Naphtol (both Sigma) for 15 minutes at room
temperature. Alkaline phosphatase-positive cells were recorded
using the Texas Red fluorescence channel.
Perfusion, Sectioning and Immunohistochemistry
Two and eight weeks after transplantation, anesthetized animals
were intracardially perfused with 50 ml 16PBS following 50 ml
4% PFA/1 PBS solution. The brains were isolated and post-fixed
with 4% PFA/1 PBS solution over night at 4uC. A vibratome
(Leica VT 1200 S) was used to prepare 40 mm sagittal sections.
Permeabilization was performed by using TBS+/+/+ (TBS 0.1 M
Tris, 150 mM NaCl, pH 7.4/0.5% Triton-X 100/0.1% Na-
Azide/0.1% Na-Citrate/5% normal goat serum) for at least 1 h.
Free floating sections were then incubated in TBS+/+/+ contain-
ing primary antibodies for 48 h on a shaker at 4uC, followed by
2 h incubation with Alexa-fluorophore conjugated secondary
antibodies (Invitrogen) and Hoechst 33342 (Invitrogen) in
TBS+/+/+ at room temperature. Following primary antibodies
were used: DCX (1:400, Abcam), TUBBIII (1:600, Covance),
human Nuclei (1:200, Millipore), Synaptophysin (1:200, Chemi-
con), NeuN (1:400, Millipore), human NCAM (1:100, Santa
Cruz), FOXA2 (1:100, Santa Cruz) and TH (1:1000, Pel-Freez).
Finally, sections were mounted in AquaMount (Dako) and
analyzed with a Zeiss LSM 710 confocal microscope.
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Quantitative RT-PCR (qRT-PCR)
Total RNA was isolated from cultured cells using RNeasy
columns (QIAGEN), according to manufacturer instructions,
including an on-column DNase digest. Isolated RNA was re-
verse-transcribed using M-MLV Reverse Transcriptase (USB)
with oligo-dT16 primers (Metabion) for 1 h at 42uC. qRT-PCR
was performed on an Applied Biosystems 7500 Real-Time PCR
system with SYBR green PCR master mix (ABI) and 56 ng of
original RNA equivalents per 20 mL PCR reaction. Cycling
conditions were 40 cycles of 15 s, 95uC/60 s 60uC. Relative
expression levels were calculated using the 222D method,
normalized to biological reference samples and using GAPDH
and ACTB as housekeeping genes.
Whole Genome Expression Analysis
DNA-free total RNA samples (500 ng) to be hybridized on
Illumina human-12 V3 expression BeadChips were processed
using a linear amplification kit (Ambion) generating biotin-labeled
cRNA (IVT duration: 14 h). This was quality-checked on a 2100
Bioanalyzer (Agilent) and hybridized as recommended and using
materials and reagents provided by the manufacturer. In
BeadStudio, raw data were background-subtracted and normal-
ized using the ‘‘cubic spline’’ algorithm. Differential gene
expression was assessed on the basis of thresholds for both
expression ratios and statistical significance employing the
‘‘Illumina custom’’ algorithm considering standard deviations
from replicate beads within each array. Signal intensities below
50% of the detection threshold were arbitrarily trimmed to the
value corresponding to 50% of detection. This procedure under-
estimates expression changes for genes undetectable in the
reference sample (or vice versa) but avoids nonsense ratios, such
as negative or unrealistically high values.
Karyotype Analysis
smNPCs at passage 25 were cultured until confluent. Three
hours before chromosome preparation, colcimid (KaryoMAX;
Invitrogen) was added to a final concentration of 0.3 mg/mL. After
this incubation, the colcemid-containing solution was removed,
the cells washed with PBS, and digested to a single-cell suspension
with prewarmed Trypsin-EDTA, diluted in DMEM, and collected
by centrifugation. The cell pellet was resuspended in 37uC
prewarmed 75 mM KCl solution and incubated at room
temperature for 7 minutes. The pellet was resuspended in ice-
cold fixation solution (3:1 methanol/acetic acid) while carefully
shaking the cell suspension. Once fixed, the cells were collected by
centrifugation and carefully resuspended in fresh fixative and
incubated for 20 minutes at 4uC. Cells were spread by dropping
different dilutions of cells in fixative on glass slides (Menzel Gla¨ser,
Thermo Scientific). The chromosomes were GTG-banded using
standard procedures. Metaphase spreads were analyzed on a Zeiss
AxioScop. 10 metaphases were analyzed from each line using the
Cytovision software (Applied Imaging Corporation).
Generation of Single-cell Clonal Lines
For the generation of single-cell clones, smNPCs were infected
with a pLenti CMV -SV40-Blasticidine construct based on the
pLenti6/V5 expression system (Invitrogen), which includes a blas-
ticidin-resistance cassette. Virus production was performed in
293T cells using the ViraPower packaging mix (Invitrogen). One
6-cm plate of 293T cells were transfected using FuGENE 6
(Roche) according to the manufacturer’s instructions with 2 mg
packaging mix and 1 mg expression construct. One day after
transfection, medium was changed for N2B27 medium. The
following day, the medium supernatant was filtered to remove
293T cells, supplemented with 6 mg/mL protamine sulfate
(Sigma), 3 mM CHIR 99021, 0.5 mM PMA, 150 mM AA, and
directly used for infection of freshly plated smNPC. The next day,
infected smNPCs were washed 4 times with PBS and fed with fresh
smNPC expansion medium. Selection with 5 mg/mL blasticidine
(PAA) in smNPC expansion medium started 2 days later and was
maintained for 2 more weeks.
Blasticidin-resistant smNPCs were digested and triturated to
single cells using accutase for 30 minutes and filtered using a 40-
mm cell strainer (BD Biosciences) to remove remaining cell
aggregates. Single cells were counted and seeded at a density of 10
cells per well on a Matrigel-coated well of a 6-well plate, together
with approximately 200,000 uninfected smNPCs in expansion
medium. Four days later, cells were again selected with 5 mg/mL
blasticidin, until only resistant, single colonies remained on the
plate that were spotted and marked. Selection was maintained for
1 more week, single colonies were picked, replated on 4-well
plates, and expanded under standard smNPC conditions, and
blasticidin resistance was continued for 1 more week to exclude
surviving non-resistant cells. Once sufficiently expanded, single
cell–derived clones were differentiated as described above.
Evaluation of Electrophysiological Function
The transmembrane current and spontaneous activity were
recorded from smNPC-derived neurons, after 3 weeks of
differentiation according to the mDAN protocol, using the
whole-cell configuration of the patch-clamp technique [33]. The
patch pipettes were fabricated from borosilicate glass on a PIP-6
pipette puller (HEKA Elektronik, Lambrecht, Germany). When
filled with pipette solution, they had tip resistances of 5–7 MV.
Recordings were done using a HEKA EPC-9 amplifier (HEKA
Elektronik, Lambrecht, Germany) and Pulse 8.61 Aqusition
Software (HEKA Elektronik, Lambrecht, Germany). Series re-
sistance and pipette and whole-cell capacitance were cancelled
electronically. Cells were perfused with a bath solution containing
(mM): NaCl 140, KCl 2.4, MgCl2 1.3, CaCl2 2.5, HEPES 10, D-
glucose 10, pH 7.4. The pipette solution contained (mM): K-
gluconate 125, NaCl 10, EGTA 1, MgATP 4, HEPES 10, D-
glucose 10, pH 7.4. All experiments were performed at room
temperature. Recordings of current-voltage relationship (‘‘I-V
curves’’) or miniature spontaneous activity (‘‘minis’’) were done in
voltage-clamp mode at holding potential 270 mV. Recordings of
spontaneous firing of action potentials (‘‘AP’’) were performed in
current-clamp mode at 0 pA holding current, i.e. at own cell’s
membrane potential.
Data were analyzed using Patcher’s Power Tool routine
(developed by Dr. F. Mendez and F. Wu¨rriehausen, MPI BPC,
Go¨ttingen, Germany) for IgorPro (WaveMetrics, Lake Oswego,
OR, USA) and Origin 7.5 (Origin Lab Corp., Northampton, MA,
USA). Minis were analyzed with Mini Analysis 6.0 software
(Synaptosoft Inc., Fort Lee, NJ, USA).
Supporting Information
Figure S1 Derivation of neural epithelial cells. (A)
Immunostaining of EBs with the indicted markers on day 6 of
differentiation after being plated for 8 hours. (B) GTG-banded
metaphase spreads for 3 independent neural epithelial cell lines
derived from either human ESCs or iPSCs as indicated, analyzed
at passage 25 to 27 and showing apparently normal diploid female
karyotypes (46, XX). (C) Doubling time of neural epithelial cells
derived from hESCs is stable over multiple passages. Neural
epithelial cells from different pluripotent cell lines have compara-
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ble doubling times. 0.5 mM is the optimal PMA concentration for
neural epithelial cell growth. When grown with PMA at
a concentration of 0.25 mM or 1 mM, the doubling time was
higher. Scale bars are 100 mm.
(TIF)
Figure S2 smNPCs differentiate into oligodendrocytes
after spontaneous differentiation. (A) After at least three
weeks of spontaneous differentiation by withdrawal of CHIR and
PMA, single O4 positive cells are interspersed in the neural
clusters, as identified by TUBBIII positive neurons. (B) Following
reseeding as single cells and recovery of one more week, single
O4/OLIG2 double positive oligodendrocytes can be identified. It
is likely that this overall efficiency was diminished by the poor
survival of oligodendrocytes to replating, which was necessary for
the experiment.
(TIF)
Figure S3 Gene expression by neural epithelial cells. (A)
Expression levels for the indicated genes derived from microarray
analysis of 2 neural epithelial cell lines and their parental human
pluripotent cell lines. Neural epithelial cells consistently expressed
neural progenitor and rosette markers, but not markers of
pluripotency or mesendodermal differentiation. (B) qRT-PCR
analysis of 2 indicated neural epithelial cell lines at the indicated
passage number for the indicated gene. OCT4, SOX2=pluripo-
tency markers. SOX2, SOX1, PAX6=neural progenitor markers.
PAX3=neural plate border marker. FOXG1=anterior neural
progenitor marker. AFP, SOX17= endodermal markers. T, CK8,
CK18=mesodermal markers. Microarray data has been deposited
in NCBI under accession number GSE40556 and can be accessed
through the link: http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?token= zzijjqwuasuugxe&acc =GSE40556
(TIF)
Figure S4 Neural epithelial cells are capable of forming
neural rosettes. (A) Phase-contrast image of smNPCs before
and after treatment with FGF2 for 2 days. (B) Immunostaining of
neural epithelial cells before and after treatment with FGF2 for
NESTIN, N-CADHERIN, and ZO-1. Arrowheads indicate N-
CADHERIN and ZO-1 expression in the center of neural rosette-
like structures, in contrast to the diffuse expression in neural
epithelial cells. Scale bars are 100 mm.
(TIF)
Figure S5 Neural epithelial cells express markers of
a moderately dorsal, hindbrain character. Microarray
data of the indicated neural epithelial cell lines for markers of
dorsoventral (A) and rostrocaudal (B) patterning. A schematic
representation of the expression patterns of these markers in vivo in
the developing neural tube is shown to the right. The black box
indicates the approximate position of neural epithelial cells. See
also Figure S2.
(TIF)
Figure S6 Differentiation of neural epithelial cells into
neural crest progenitors. (A) qRT-PCR of neural epithelial
cells after treatment with CHIR or BMP4 for 6 days for the neural
crest markers PAX7 and SOX9 and TFAP2A. (B) Immunostaining
for TFAP2A after differentiation of neural epithelial cells with
CHIR for 2 days followed by BMP4 for two days, indicating
a strong increase in TFAP2A positive cells. (C) After maturation,
PNS-differentiated cells give rise to PERIPHERIN/TFAP2A
double – positive cells. (C) Confocal imaging demonstrating
BRN3A and PERIPHERIN double-positive peripheral neurons.
(D) Immunostaining of primary human fibroblasts (hFib) or neural
epithelial cell–derived mesenchymal cells differentiating and
cultured with serum for the indicated mesenchymal markers. (E)
After 14 days of differentiation with the Human Mesenchymal
Stem Cell Functional Identification Kit (R&D Systems), neural
epithelial cell–derived cells were assessed for alkaline phosphatase
activity and OSTEOCALCIN expression, which are markers of
osteocytes, as well as for cells containing oil droplets with FABP4
expression, which is a marker of adipocytes. Scale bars are
100 mm.
(TIF)
Figure S7 Clonal differentiation into CNS and PNS
lineages. (A) Phase-contrast images of 3 independent single
cell–derived neural epithelial cell colonies that were picked and
expanded. (B) Immunostaining of the resulting clonal neural
epithelial cell lines for the indicated neural progenitor markers. (C)
Immunostaining for mDANs (TH/FOXA2), MNs (ISLET1/
TUBIII), and PNS sensory (PERIPHERIN/BRN3A) neurons
from the 3 clonal neural epithelial cell lines. (D) Clonally derived
lines are multipotent and can give rise to neurons (MAP2),
astrocytes (GFAP) and oligodendrocytes (O4/OLIG2) by sponta-
neous differentiation. Scale bars are 100 mm.
(TIF)
Figure S8 smNPC-derived neurons acquire excitable
properties of neuronal cells. (A–E) Amplitude and kinetic
parameters (n = 7 cells) and an exemplary recording of minis (F)
performed at holding potential 270 mV after two to three weeks
of maturation.
(TIF)
Figure S9 In vivo differentiation potential and long-
term survival of transplanted smNPCs. (A) Already after
two weaks of maturation in vivo, smNPCs form mature, post-
mitoctic neurons, as shown by NeuN and human – specific
NCAM staining. (B–E) Eight weeks post transplantation, smNPCs
have formed and survived as neurons and astrocytes, as shown by
staining for DCX, TUBBIII and GFAP and form multiple
synapses, as shown by staining for SYNAPTOPHYSIN. (F) After
eight weeks, smNPCs prepatterned to an mDAN fate give rise to
TH and FOXA2 double positive cells. Without prepatterning, cells
are negative for FOXA2 (not shown). (G) Also mDAN-pre-
patterned smNPCs form synapses as shown by SYNAPTOPHY-
SIN staining.
(TIF)
Figure S10 Human iPSC-derived smNPCs. 2 independent
smNPC lines were derived from iPSCs. The results of all
experiments with hiPSC-derived smNPCs were directly compara-
ble to those with hESC-derived smNPCs. (A) Immunostaining
results for the indicated neural progenitor markers. Immunostain-
ing of PNS neurons (B), mDANs (C), and MNs (D) differentiated
from the iPSC-derived smNPCs. Scale bars are 100 mm.
(TIF)
Figure S11 LRRK2 G2019S increases sensitivity of
dopaminergic neurons derived from smNPCs to stress
compared with controls. smNPCs were derived from two
patient-specific LRRK2 mutant iPSCs, alongside with two age-
and sex-matched controls. smNPCs were differentiated into
mDANs, replated as single cells and incubated with N2 medium
only, or supplemented with 5 mM 6-Hydroxydopamine (6-
OHDA), or 10 mM 6-OHDA, or 100 nM rotenone. After two
days, apoptotic mDANs were identified by immunostaining for
TH and cleaved CASPASE3 (CASP3). Error bars represent
variation between two independently stressed wells. (A) LRRK2
mutant mDANs show a higher degree of apoptosis in TH+ cells, as
compared to healthy controls. (B) Additional stressors separate the
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mDAN cytotoxicity phenotype better between LRRK2 mutant
and wild-type neurons than withdrawal of antioxidants and
neurotrophins alone. *indicates p,0.05 according to the Student’s
t-test.
(JPG)
Figure S12 smNPC-derived mDANs are specifically
susceptible to oxidative stress. (A) Overview image of
a stressed dopaminergic neuron culture after differentiation from
smNPCs stressed with 6 OH-Dopa for two days before fixation.
Cultures were stained with the indicated markers. Note that most
of the cells positive for cleaved CASPASE3 (CASP3) as an
indicator for apoptosis are also positive for TH. Only few CASP3+
cells are negative for TH (some indicated by arrowheads). The
scale bar indicates 100 mm. (B) Stressed cultures were stained for
TH and CASP3 and counted. The graph indicates a high
specificity of stress-induced apoptosis for dopaminergic neurons as
shown by CASP3 and TH double-positive cells. Under the tested
conditions, more than about 80% of the CASP3-positive cells also
express TH. The experiment was performed in duplicates. Error
bars indicate variance.
(TIF)
Table S1 Primers used for qRT-PCR used in this study.
(DOCX)
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